Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Hematology
    • Hereditary Genetic Disorders
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Nephrologic/Hepatologic Conditions
    • Neurological Diseases
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jheor.org/feed
×
Other Conditions
Vol. 2, Issue 2, 2015July 15, 2015 EDT

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

Mike Durkin, Jacqueline Pesa, Jessica Lopatto, Rachel Halpern, Damon Van Voorhis, Stephanie Korrer,
oxycodone cr tapentadol er resource use health care costs chronic pain
Copyright Logoccby-4.0 • https://doi.org/10.36469/9905
Photo by Simone van der Koelen on Unsplash
JHEOR
1.
Durkin M, Pesa J, Lopatto J, Halpern R, Van Voorhis D, Korrer S. Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR. JHEOR. 2015;2(2):221-232. doi:10.36469/9905
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)

View more stats

Powered by Scholastica, the modern academic journal management system